论文部分内容阅读
目的观察血液透析联合血液灌注治疗难治性高血压的效果。方法选取2014年3月-2015年3月在医院接受治疗的患有难治性高血压的患者86例,并随机分为试验组和对照组各43例。试验组采取在普通血液透析的基础上再进行血液灌注的治疗方案,对照组采取的治疗方案为仅进行血液透析。经过3个月的治疗后,对2组患者临床取得的治疗效果进行对比观察。结果试验组总有效率为93.02%明显高于对照组的65.12%,差异有统计学意义(P<0.05)。试验组满意度为97.67%明显高于对照组的69.77%,差异有统计学意义(P<0.05)。结论对难治性高压患者实施血液透析联合血液灌注方案无论是在临床方面取得的治疗效果还是患者的满意度方面,均高于普通采取血液透析的方案,因此,建议临床多采取血液透析联合血液灌注的治疗方案。
Objective To observe the effect of hemodialysis combined with blood perfusion in the treatment of refractory hypertension. Methods Totally 86 patients with refractory hypertension who were treated in hospital from March 2014 to March 2015 were selected and randomly divided into experimental group and control group of 43 cases. In the experimental group, hemodialysis was performed on the basis of conventional hemodialysis. The control group took the hemodialysis only. After 3 months of treatment, the clinical efficacy of the two groups of patients were compared. Results The total effective rate was 93.02% in the experimental group was significantly higher than 65.12% in the control group, the difference was statistically significant (P <0.05). The satisfaction rate of the experimental group was 97.67%, which was significantly higher than that of the control group (69.77%), the difference was statistically significant (P <0.05). Conclusion Hemodialysis combined with blood perfusion in patients with intractable hypertension is superior to the routine hemodialysis in both the clinical treatment and patient satisfaction, so it is recommended to take more clinical hemodialysis combined with blood Perfusion of treatment options.